unless there way of positive EBITDA is stop spending for international clearances then they would be right but there goes any chance at growth for gss
Ann: Decision to Cease Development of US Respiratory Product, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.005(1.30%) |
Mkt cap ! $88.58M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 39.0¢ | $15.79K | 40.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 34800 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 95869 | 1 |
View Market Depth
| Last trade - 14.59pm 17/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |